Xybion Corporation announced today that Pfizer Inc. (NYSE:PFE) has
selected Xybion’s Pristima Suite to manage its global Drug Safety R&D
(DSRD) data management operations. Pristima, a complete off-the-shelf
turn-key solution, is a Software as a Service (SaaS) model that
consolidates several systems and applications into a single, global
solution.
Under the terms of the agreement, Pfizer will implement a suite of
Pristima modules for DSRD data management and reporting of toxicology
studies. Licensed modules include the Pristima SEND module to support
CDISC regulatory electronic data submission and Pristima Savante™ to
aggregate, analyze and visualize data from a central data repository
(CDR).
As a large component of the project, Xybion will provide a number of
services for Pfizer’s implementation of Pristima, including the
utilization of Xybion’s services to facilitate Pristima validation.
Pfizer may also leverage Xybion’s training and implementation services
to train personnel and configure Pristima to meet Pfizer’s best
practices and reporting specifications.
Dr. Pradip Banerjee, CEO at Xybion stated, “Xybion is delighted to
welcome Pfizer to our client community and we are energized and excited
to deliver on this global project. We recognize that Pfizer was a
significant contributor to the requirements and conceptualization of
Pristima, so it is extremely satisfying to see Pfizer has selected
Pristima for its DSRD data management operations.”
Key Facts:
-
Multi-year agreement with online deployment project beginning in 2014
-
Competitive evaluation conducted and Pristima selected utilizing
Xybion’s SaaS model
-
Agreement includes Pristima’s In-vivo, Clinical Pathology, Pathology,
Statistics and Reporting Modules
-
Licensed Pristima modules also include Pharmacy, Histology, SEND and
Savante™, all of which extend Pristima’s leading functional advantages
-
Pristima delivered as a SaaS model can reduce support costs and IT
requirements while supporting a hypercare customer service strategy
option
ABOUT XYBION
Xybion is the leading provider of software, services and consulting for
global corporations operating in highly regulated industries. Our unique
solutions focus on integrated preclinical lab management, early-stage
drug discovery, regulatory compliance, GRC, quality management and
systems validation.
Xybion's combination of software, business process management, services,
validation and staffing enables us to cover a broad spectrum of critical
business needs for companies and we deliver our solutions on global
scale. Our leadership in this dynamic and ever-changing industry has
been a cornerstone of our high-value reputation. To learn more, please
visit www.xybion.com.
Copyright Business Wire 2014